Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
One big firm filed for consolidation of the Ozempic lawsuit, allegedly without much warning to other law firms
GLP-1 and GIP/GLP-1 medications have boxed warnings regarding thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and carry risks of pancreatitis, gallbladder disease, and diabetic retinopathy progression
Current shortage status of GLP-1 products (as of October 02, 2024): Tirzepatide injection: Shortage resolved
Future research should explore long-term safety, efficacy in combination with SGLT2 inhibitors, and the role of multi-agonist therapies targeting GIP, glucagon, or amylin pathways
IBS Pain and Bloating: One intriguing aspect is the effect of GLP-1 on the hallmark IBS symptom of abdominal pain (often due to gut spasm and visceral hypersensitivity)
US$ 25.32
US$ 21.99
US$ 22.15
US$ 24.52
US$ 25.62
US$ 29.92
US$ 29.61
US$ 24.14
